AAAAAA

   
Results: 1-10 |
Results: 10
OPTIMAL VACCINE TRIAL DESIGN WHEN ESTIMATING VACCINE EFFICACY FOR SUSCEPTIBILITY AND INFECTIOUSNESS FROM MULTIPLE POPULATIONS
Authors: LONGINI IM SAGATELIAN K RIDA WN HALLORAN ME
Citation: Im. Longini et al., OPTIMAL VACCINE TRIAL DESIGN WHEN ESTIMATING VACCINE EFFICACY FOR SUSCEPTIBILITY AND INFECTIOUSNESS FROM MULTIPLE POPULATIONS, Statistics in medicine, 17(10), 1998, pp. 1121-1136
HIV VACCINES
Authors: ELLENBERG SS RIDA WN
Citation: Ss. Ellenberg et Wn. Rida, HIV VACCINES, Lancet, 349(9048), 1997, pp. 361-361
ASSESSING THE EFFECT OF HIV VACCINATION ON INFECTIOUSNESS
Authors: RIDA WN
Citation: Wn. Rida, ASSESSING THE EFFECT OF HIV VACCINATION ON INFECTIOUSNESS, Statistics in medicine, 15(21-22), 1996, pp. 2393-2404
STATISTICAL ISSUES IN THE DESIGN OF HIV VACCINE TRIALS
Authors: SCHAPER C FLEMING TR SELF SG RIDA WN
Citation: C. Schaper et al., STATISTICAL ISSUES IN THE DESIGN OF HIV VACCINE TRIALS, Annual review of public health, 16, 1995, pp. 1-22
IMPACT OF IMPROVED TREATMENT OF SEXUALLY-TRANSMITTED DISEASE ON HIV-INFECTION
Authors: FOULKES MA RIDA WN HOFF R
Citation: Ma. Foulkes et al., IMPACT OF IMPROVED TREATMENT OF SEXUALLY-TRANSMITTED DISEASE ON HIV-INFECTION, Lancet, 346(8983), 1995, pp. 1158-1158
SOME STATISTICAL ISSUES IN HIV VACCINE TRIALS
Authors: RIDA WN LAWRENCE DN
Citation: Wn. Rida et Dn. Lawrence, SOME STATISTICAL ISSUES IN HIV VACCINE TRIALS, Statistics in medicine, 13(19-20), 1994, pp. 2155-2177
PREPARATIONS FOR HIV VACCINE EFFICACY TRIALS
Authors: VERMUND SH LAWRENCE DN FISCHER RD FAST P RIDA WN SCHRAGER LK BRADAC J SHEON AR CORDELL JR DUNBAR S BARKER LF HOFF R
Citation: Sh. Vermund et al., PREPARATIONS FOR HIV VACCINE EFFICACY TRIALS, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 746-746
HIV VACCINE TRIALS - SOME DESIGN ISSUES INCLUDING SAMPLE-SIZE CALCULATION
Authors: DIXON DO RIDA WN FAST PE HOTH DF
Citation: Do. Dixon et al., HIV VACCINE TRIALS - SOME DESIGN ISSUES INCLUDING SAMPLE-SIZE CALCULATION, Journal of acquired immune deficiency syndromes, 6(5), 1993, pp. 485-496
HELD IN CONJUNCTION WITH THE CONFERENCE ON ADVANCES IN AIDS VACCINE DEVELOPMENT 5TH ANNUAL-MEETING, NATIONAL COOPERATIVE VACCINE DEVELOPMENT GROUPS ON AIDS (CHANTILLY, VIRGINIA, AUGUST 30-SEPTEMBER 2, 1992)
Authors: LAWRENCE DN RIDA WN SHEON A FISCHER RD HOFF R
Citation: Dn. Lawrence et al., HELD IN CONJUNCTION WITH THE CONFERENCE ON ADVANCES IN AIDS VACCINE DEVELOPMENT 5TH ANNUAL-MEETING, NATIONAL COOPERATIVE VACCINE DEVELOPMENT GROUPS ON AIDS (CHANTILLY, VIRGINIA, AUGUST 30-SEPTEMBER 2, 1992), AIDS research and human retroviruses, 9, 1993, pp. 190000125-190000126
PREPARING FOR HIV VACCINE EFFICACY TRIALS - PARTNERSHIPS AND CHALLENGES
Authors: VERMUND SH FISCHER RD HOFF R RIDA WN SHEON AR LAWRENCE DN HOTH DF BARKER LF
Citation: Sh. Vermund et al., PREPARING FOR HIV VACCINE EFFICACY TRIALS - PARTNERSHIPS AND CHALLENGES, AIDS research and human retroviruses, 9, 1993, pp. 190000127-190000132
Risultati: 1-10 |